X

The U.S. Election Cannabis Playbook Part 1

The election night playbook will take you through the three potential election scenarios and how they will impact cannabis laws…

We Are Witnessing the Beginning of the End of the Deflationary Era

The cyclical trade continues to be recommended here, despite the ongoing COVID “second wave”. On this point, it is interesting…

Aphria 1Q 2021 Earnings – Prices in Freefall

Aphria reported disappointing revenue that missed expectation by 8% and was also a decline from last quarter. The market hates…

What Happened to Fastly Stock?

When a stock falls 30% in one day, investor's take notice. Fastly was that stock on October 15th. In this…

Test Grid

Real World Options Trades: Beyond Meat-Test

Expensive Green New Deal will Drive Energy Prices Higher not Lower

The Economist has a long-established tradition of contrarian cover signals, as have other business magazines, some of which are now…

The Virus is Burning Itself Out, Buy Stock Market Weakness

Joe Biden’s most important running mate, Covid-19, has clearly turned massively in his favour. The 7-day average daily new case…

Markets & COVID-19: Dave Collum – Prof. of Organic Chemistry at Cornell

Grizzle had the pleasure of sitting down with Dave Collum, Professor of Organic Chemistry at Cornell University. An engaging and…

Why Compass Pathways (CMPS) is a 5-bagger: $210/share

https://youtu.be/lgZbRvQfhPg Grizzle identified Compass Pathways as our conviction call IPO, our primer laid out the opportunity (Sept 18/2020).  The stock's…